Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia Corporate presentation – January 2020 de adocia

Latest Press Releases

2020/05/11Number of shares and voting rights of ADOCIA as of April 30, 2020
2020/04/23Adocia announces the release of its Universal Reference Document for the year 2019

All Press releases

Next events

June 8-11, 2020 BIO International Convention, San Diego, USA - The world's largest global biotechnology partnering event. Virtual event in the exceptional setting of COVID-19.

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

SFD 2020: Adocia will be presenting M1 Pram (ADO09) at the occasion of Francophone Diabetes Society Congress in Brussels, Belgium next September, 2020

April 27, 2020 Adocia conference call is available in transcript and replay